Doctor concerned with health care law

Breaking news and expert analysis on legal and compliance issues

[Back To Home][Back To Archives]

From Health Law Daily, August 26, 2014

Chronic use drives rise in opioid consumption among Medicare disabled

By Sarah E. Baumann, JD

An increase in chronic users may be the reason behind increased opioid consumption among disabled Medicare beneficiaries. A study of disabled beneficiaries under age 65 published in Medical Care showed that the percentage of beneficiaries with any opioid use decreased slightly from 43.9 percent in 2007 to 43.7 in 2011. However, the percentage of chronic users rose from 21.4 percent to 23.1 percent. Although they recognize that some chronic use can be beneficial, the authors suggest that Medicare administrators and clinicians find ways to monitor pain management to avoid unnecessary use.

Study. The authors were interested in opioid use among disabled workers who received social security disability benefits due to musculoskeletal conditions, which are commonly treated with opioids. They examined opioid prescription fill patterns among a pool of disabled Medicare beneficiaries under age 65, as SSDI beneficiaries make up most of that group, from 2007 through 2011. Individuals were present an average of 3.3 of the 58 years studied.

Results. Overall use peaked in 2010, but declined slightly in 2011. However, chronic use increased. In the authors’ words, the chronic use was “intense,” with 20 percent receiving 100 milligrams of morphine equivalents per day and 10 percent receiving 200 milligrams or more. Although musculoskeletal conditions are more prevalent in the disabled Medicare population (65 percent compared to 50 percent in the general U.S. adult population) and even more extreme among chronic users (94 percent), this did not appear to account for chronic use. The presence of regional differences in prescription fills regardless of the strictness of state drug laws was troubling to the authors, because it suggested inconsistent approaches. For example, “oxycodone was prominent on the eastern seaboard, whereas Texas prescribers all but eschewed these products,” despite similar regulations among states.

The authors encourage the possible use of quality measures for chronic opioid management, as well as measures to limit the number of prescribers per user, monitoring, and consultations with pain specialists. They recognize that such programs will require expenditures. However, they believe “inaction will also come at a substantial cost.”

MainStory: TopStory NewsStory DrugNews ControlledNews DrugBiologicalNews PartANews PartBNews PartDNews PrescriptionDrugNews

Health Law Daily

Introducing Wolters Kluwer Health Law Daily — a daily reporting service created by attorneys, for attorneys — providing same-day coverage of breaking news, court decisions, legislation, and regulatory activity.


A complete daily report of the news that affects your world

  • View full summaries of federal and state court decisions.
  • Access full text of legislative and regulatory developments.
  • Customize your daily email by topic and/or jurisdiction.
  • Search archives for stories of interest.

Not just news — the right news

  • Get expert analysis written by subject matter specialists—created by attorneys for attorneys.
  • Track law firms and organizations in the headlines with our new “Who’s in the News” feature.
  • Promote your firm with our new reprint policy.

24/7 access for a 24/7 world

  • Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues.
  • Save time with mobile apps for your BlackBerry, iPhone, iPad, Android, or Kindle.
  • Access all links from any mobile device without being prompted for user name and password.